A. Goudeau

发表

Polymorphism in programmed cell death 1 gene is strongly associated with lung and kidney allograft survival in recipients from CMV-positive donors.

F. Ivanes, C. Forconi, P. Gatault, 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Emergence of blaNDM-7–Producing Enterobacteriaceae in Gabon, 2016

P. François, S. Diene, A. Goudeau, 2017, Emerging infectious diseases.

Letter: Cross-reaction of human serum-proteins with HBsAg.

J. Dankert, B. Houwen, A. Goudeau, 1974, Lancet.

Fine serotyping of human immunodeficiency virus serotype 1 (HIV-1) and HIV-2 infections by using synthetic oligopeptides representing an immunodominant domain of HIV-1 and HIV-2/simian immunodeficiency virus

A. Goudeau, F. Barin, A. Baillou, 1991, Journal of clinical microbiology.

Linear B-cell epitopes of the major core protein of human immunodeficiency virus types 1 and 2

A. Goudeau, B. Mandrand, F. Barin, 1990, Journal of virology.

A Potential New Human Pathogen Belonging to Helicobacter Genus, Identified in a Bloodstream Infection

F. Mégraud, E. Gontier, P. François, 2017, Front. Microbiol..

Detection of Bartonella in cat scratch disease using a single‐step PCR assay kit

A. Goudeau, P. Lanotte, C. Le Brun, 2017, Journal of medical microbiology.

Combined passive and active immunization for interruption of perinatal transmission of hepatitis B virus in Taiwan.

P. Coursaget, B. Chiang, A. Goudeau, 1985, Hepato-gastroenterology.

Hepatitis Delta Virus

H. Handa, P. Roingeard, Y. Yamaguchi, 2006 .

HEPATITIS B VIRUS INFECTION IN INFANTS OF ANTI-HBs POSITIVE MOTHERS

P. Coursaget, A. Goudeau, J. Chiron, 1981, The Lancet.

Association Between a Polymorphism in the IL-12p40 Gene and Cytomegalovirus Reactivation After Kidney Transplantation

T. S. Houssaini, T. Hoffmann, A. Goudeau, 2008, Transplantation.

Analysis of residual perinatal transmission of hepatitis B virus (HBV) and of genetic variants in human immunodeficiency virus and HBV co-infected women and their offspring.

A. Moreau, C. Gaudy-Graffin, A. Goudeau, 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Influence of human immunodeficiency virus infection on hepatitis δ virus superinfection in chronic HBsAg carriers

P. Roingeard, F. Carnot, C. Bréchot, 1994, Journal of viral hepatitis.

Usefulness of a Fourth Generation ELISA Assay for the Reliable Identification of HCV Infection in HIV-Positive Adults from Gabon (Central Africa)

F. Liégeois, C. Gaudy-Graffin, A. Goudeau, 2015, PloS one.

Epidemiology and eradication strategy for hepatitis B in Europe. The European Regional Study Group.

A. Goudeau, 1990, Vaccine.

Incidence and prevalence of hepatitis B in France.

A. Goudeau, F. Dubois, F. Dubois, 1995, Vaccine.

Urogenital, maternal and neonatal isolates of Haemophilus influenzae: identification of unusually virulent serologically non-typable clone families and evidence for a new Haemophilus species.

J. Musser, R. Selander, A. Smith, 1990, Journal of general microbiology.

Genetic characterization of a cryptic genospecies of Haemophilus causing urogenital and neonatal infections

J. Musser, A. Goudeau, C. Martín, 1993, Journal of clinical microbiology.

Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease.

J. Musser, R. Selander, A. Goudeau, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Characterization of Streptococcus agalactiae strains by multilocus enzyme genotype and serotype: identification of multiple virulent clone families that cause invasive neonatal disease

R. Selander, P. Geslin, A. Goudeau, 1995, Journal of clinical microbiology.

Long-Term Hepatitis B Virus (HBV) Response to Lamivudine-Containing Highly Active Antiretroviral Therapy in HIV-HBV Co-Infected Patients in Thailand

A. Moreau, C. Gaudy-Graffin, A. Goudeau, 2012, PloS one.

Hepatitis C in a Hemodialysis Unit: Molecular Evidence for Nosocomial Transmission

R. Christen, A. Goudeau, S. Pogam, 1998, Journal of Clinical Microbiology.

Detection of an antigen‐antibody system in serum associated with human non‐A, non‐B hepatitis

A. Goudeau, E. Tabor, R. Gerety, 1979, Journal of medical virology.

Diagnosis of community-acquired acute respiratory illness: From conventional microbiological methods to molecular detection (multiplex)

C. Gaudy-Graffin, A. Goudeau, D. Garot, 2015, Pathologie Biologie.

Symptomatic HIV-2 primary infection

A. Goudeau, F. Barin, J. Besnier, 1990, The Lancet.

Hepatitis B virus core antigen (HBc Ag) accumulation in an HBV nonproducer clone of HepG2-transfected cells is associated with cytopathic effect.

P. Roingeard, D. Leturcq, A. Goudeau, 1990, Virology.

LACK OF ANTI-HBc IgM IN NEONATES WITH HBsAg CARRIER MOTHERS ARGUES AGAINST TRANSPLACENTAL TRANSMISSION OF HEPATITIS B VIRUS INFECTION

B. Yvonnet, P. Coursaget, A. Goudeau, 1983, The Lancet.

Detection of avian oncogenic Marek's disease herpesvirus DNA in human sera.

G. Dambrine, D. Choudat, D. Rasschaert, 2001, The Journal of general virology.

Prevalence and persistence of antibody titers to recombinant HIV-1 core and matrix proteins in HIV-1 infection.

G. Vernet, P. Dalbon, V. Cheynet, 1993, Journal of acquired immune deficiency syndromes.

Ultrastructural and physicochemical characterization of the hepatitis C virus recovered from the serum of an agammaglobulinemic patient

P. Roingeard, Y. Bacq, A. Goudeau, 1998, Archives of Virology.

Prevention of hepatitis B virus infection in children born to HBsAg positive/HBeAg positive mothers. Preliminary results of active and passive-active immunization.

P. Coursaget, S. Yeh, A. Goudeau, 1983, Developments in biological standardization.

Predicting the microbial cause of community-acquired pneumonia: can physicians or a data-driven method differentiate viral from bacterial pneumonia at patient presentation?

P. Asfar, A. Goudeau, H. Blasco, 2019, BMC Pulmonary Medicine.

Deep sequencing is an appropriate tool for the selection of unique Hepatitis C virus (HCV) variants after single genomic amplification

A. Moreau, P. Vourc'h, C. Gaudy-Graffin, 2017, PloS one.

Application of the French guidelines for preventing neonatal group B streptococcal disease in a university hospital.

A. Goudeau, M. Chevillot, P. Lanotte, 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Persistent delta antigenaemia in chronic delta hepatitis and its relation with human immunodeficiency virus infection

P. Marcellin, P. Roingeard, J. Bernuau, 1992, Journal of medical virology.

PREVALENCE OF HUMAN T-LYMPHOTROPIC RETROVIRUSES TYPE III (HIV) AND TYPE IV IN IVORY COAST

A. Goudeau, M. Essex, P. Kanki, 1987, The Lancet.

AUTHOR ' S CORRECTION Immune Response to a Major Epitope of p 24 during Infection with Human Immunodeficiency Virus Type 1 and Implications for Diagnosis and Prognosis

A. Goudeau, B. Mandrand, F. Barin, 2022 .

Multicentre evaluation of a new commercial latex agglutination test using a monoclonal antibody for rotavirus detection

E. Kohli, P. Pothier, A. Goudeau, 1989, European Journal of Clinical Microbiology and Infectious Diseases.

Genetic diversity of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis revealed by restriction fragment length polymorphism of the rRNA gene region

A. Goudeau, C. Martín, R. Quentin, 1995, Journal of clinical microbiology.

Prospective assessment of FilmArray® technology for the rapid identification of yeast isolated from blood cultures.

A. Goudeau, P. Lanotte, E. Gyan, 2014, Journal of microbiological methods.

Relapse of Herpes Simplex Encephalitis

P. Lebon, F. Rozenberg, M. Tardieu, 1995, Journal of child neurology.

Hepatitis B infection in alcoholic liver disease and primary hepatocellular carcinoma in France.

P. Coursaget, A. Goudeau, P. Bougnoux, 1981, Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progres en virologie medicale.

EFFICACY OF HEPATITIS B VACCINE IN PREVENTION OF EARLY HBsAg CARRIER STATE IN CHILDREN Controlled Trial in an Endemic Area (Senegal)

P. Coursaget, A. Goudeau, J. Chiron, 1981, The Lancet.

Immune Response to a Major Epitope of p24 during Infection with Human Immunodeficiency Virus Type 1 and Implications for Diagnosis and Prognosis

A. Goudeau, B. Mandrand, F. Barin, 1992, Antimicrobial Agents and Chemotherapy.

Use of nonradioactive DNA probes to identify aCampylobacter jejuni strain causing abortion

J. Guesdon, A. Goudeau, C. Martín, 1993, European Journal of Clinical Microbiology and Infectious Diseases.

Use of Nonradioactive DNA Probes to Identify a Campylobacterjejuni

S. Briançon, A. Goudeau, C. Martín, 1993 .

Outbreak in France of Neisseria meningitidis B:15:P1.12 belonging to sequence type 1403.

A. Goudeau, M. Taha, P. Lanotte, 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Large-scale isolation of the two major polypeptides of the hepatitis B surface antigen (HBsAg) by gel filtration in 6 M guanidinium chloride.

A. Goudeau, F. Barin, M. Hubert, 1982, Journal of virological methods.

[Transmission by colonoscopy of hepatitis C virus: apropos of a group of 97 patients at "presumed risk"].

P. Blanc, A. Goudeau, F. Dubois, 1999, Gastroenterologie clinique et biologique.

Serum alanine aminotransferase measurement as a guide to selective testing for hepatitis C during medical checkup.

P. Roingeard, N. Mariotte, J. Tichet, 1994, Journal of hepatology.

Isolation of hepatitis B surface antigen (HBsAg) by affinity chromatography on antibody-coated immunoadsorbents.

J. Dankert, B. Houwen, A. Goudeau, 1975, Journal of immunological methods.

Automated complement fixation test for the detection of antibodies against the core of hepatitis B virus (HBc).

P. Coursaget, A. Goudeau, I. Millman, 1976, Journal of immunological methods.

Immunogenicity in chimpanzees of experimental hepatitis B vaccines prepared from intact hepatitis B virus, purified polypeptides, or polypeptide micelles

A. Zuckerman, C. Howard, P. Snoy, 1982, Journal of medical virology.

Frequent isolation of capnophilic bacteria in aspirate from Bartholin's gland abscesses and cysts

M. Dubois, A. Goudeau, R. Quentin, 1990, European Journal of Clinical Microbiology and Infectious Diseases.

Hepatitis B e antigen and alpha-ftoprotein in black african people suffering from liver cirrhosis

B. Yvonnet, P. Coursaget, A. Goudeau, 1982 .

Epidemiological and serological study of hepatitis A virus outbreaks in France: a comparison between immunoadherence and radioimmunoassay

P. Coursaget, P. Hibon, G. Lelord, 1981, Journal of Hygiene.

Frequent and early in utero HIV-1 infection.

C. Bréchot, A. Goudeau, F. Barin, 1991, AIDS research and human retroviruses.

Randomized dose range study of a recombinant hepatitis B vaccine produced in mammalian cells and containing the S and PreS2 sequences.

C. Bréchot, A. Laplanche, F. Degos, 1989, The Journal of infectious diseases.

Association between a polymorphism in the human programmed death-1 (PD-1) gene and cytomegalovirus infection after kidney transplantation

T. Hoffmann, A. Goudeau, Y. Lebranchu, 2009, Journal of Medical Genetics.

Use of an Anti-Hepatitis C Virus (HCV) IgG Avidity Assay To Identify Recent HCV Infection

C. Gaudy-Graffin, A. Goudeau, S. Laperche, 2010, Journal of Clinical Microbiology.

HBsAg-negative chronic active hepatitis related to hepatitis B virus

P. Coursaget, A. Goudeau, J. Benhamou, 1978, Medical Microbiology and Immunology.

Immunogenicity of hepatitis B vaccine in guinea-pigs, mice and man.

A. Goudeau, M. Girard, M. Mazert, 1985, Journal of biological standardization.

Viral safety of a new highly purified factor VIII (OCTATE)

S. Lemon, A. Goudeau, L. Biesert, 1996, Journal of medical virology.

Hepatitis B core antigen in hepatocytes of patients with chronic active hepatitis

C. Degott, C. Bréchot, C. Trépo, 1980, Digestive Diseases and Sciences.

TRANSMISSION OF HEPATITIS B FROM HEPATITIS-B-SERONEGATIVE SUBJECTS

C. Bréchot, H. Schellekens, A. Goudeau, 1988, The Lancet.

Human immunodeficiency virus antigenemia in patients with AIDS and AIDS-related disorders: a comparison between European and Central African populations.

A. Goudeau, F. Barin, A. Baillou, 1987, The Journal of infectious diseases.

Adherence to human cells of a cryptic Haemophilus genospecies responsible for genital and neonatal infections

J. Musser, A. Goudeau, P. Sizaret, 1993, Infection and immunity.

Combination of β‐(1, 3)‐D‐glucan testing in serum and qPCR in nasopharyngeal aspirate for facilitated diagnosis of Pneumocystis jirovecii pneumonia

A. Goudeau, G. Desoubeaux, A. Chesnay, 2019, Mycoses.

In vitro activities of five new quinolones against 88 genital and neonatal Haemophilus isolates

A. Goudeau, R. Quentin, B. Cattier, 1988, Antimicrobial Agents and Chemotherapy.

Factors associated with influenza vaccination failure and severe disease in a French region in 2015

D. Marc, C. Gaudy-Graffin, A. Goudeau, 2018, PloS one.

High Burden of Non-Influenza Viruses in Influenza-Like Illness in the Early Weeks of H1N1v Epidemic in France

François Simon, Matthieu Resche-Rigon, P. Taboulet, 2011, PloS one.

[Systematic screening tests for Chlamydia trachomatis, Mycoplasma hominis and Ureaplasma urealyticum in urogenital specimens of infertile couples].

A. Goudeau, P. Lanotte, D. Royère, 2006, Pathologie-biologie.

Pasteurella multocida and female genital carcinoma; a case report to dispute the concept of genital opportunistic pathogen.

A. Goudeau, J. Lansac, R. Quentin, 1991, European journal of obstetrics, gynecology, and reproductive biology.

Evaluation of four commercial methods for identification and biotyping of genital and neonatal strains ofHaemophilus species

A. Goudeau, C. Martín, R. Quentin, 1992, European Journal of Clinical Microbiology and Infectious Diseases.

Novel Human Reovirus Isolated from Children with Acute Necrotizing Encephalopathy

P. Roingeard, G. Vernet, A. Goudeau, 2011, Emerging infectious diseases.

Diversity of antibody binding to V3 peptides representing consensus sequences of HIV type 1 genotypes A to E: an approach for HIV type 1 serological subtyping.

C. Mathiot, A. Goudeau, F. Barin, 1996, AIDS research and human retroviruses.

IMMUNISATION AGAINST HEPATITIS B IN MAN

P. Coursaget, P. Bagros, A. Goudeau, 1976, The Lancet.

Multivariate analysis of prognostic factors in fulminant hepatitis B

B. Yvonnet, C. Degott, J. Bernuau, 1986, Hepatology.

Usefulness of the Hepatitis C Virus Core Antigen Assay for Screening of a Population Undergoing Routine Medical Checkup

Jean Tichet, N. Mariotte, J. Tichet, 2005, Journal of Clinical Microbiology.

Sustained virologic response with ribavirin in chronic hepatitis E virus infection in heart transplantation.

A. Chaillon, A. Goudeau, A. de Muret, 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Multiplication of hepatitis B virus in fulminant hepatitis B.

C. Bréchot, J. Bernuau, A. Goudeau, 1984, British medical journal.

Comparative multicentre study of the immunogenicity of different hepatitis B vaccines in healthy volunteers.

A. Goudeau, M. Ballet, F. Denis, 1987, Postgraduate medical journal.

Immunoprophylaxis of infection with hepatitis B virus in infants born to hepatitis B surface antigen-positive carrier mothers.

P. Coursaget, B. Chiang, S. Yeh, 1985, The Journal of infectious diseases.

Prevalence, risk factors, and impact of isolated antibody to hepatitis B core antigen and occult hepatitis B virus infection in HIV-1-infected pregnant women.

S. Nanta, C. Gaudy-Graffin, A. Goudeau, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Further studies on production and characterization of HBsAg derived from a human hepatoma cell line (PLC/PRF/5).

C. Sureau, A. Goudeau, F. Barin, 1983, Developments in biological standardization.

Kinetics of delta antigen and delta antibody in acute delta hepatitis: evaluation with different enzyme immunoassays

A. Goudeau, F. Dubois, 1988, Journal of clinical microbiology.

Both pre-S1 and S domains of hepatitis B virus envelope proteins interact with the core particle.

C. Hourioux, P. Roingeard, A. Goudeau, 1997, Virology.

Epidemiology of primary hepatocellular carcinoma in Senegal.

P. Coursaget, A. Goudeau, J. Chiron, 1981, Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progres en virologie medicale.

IMMUNE STATUS OF ANTI-HBc POSITIVE INDIVIDUALS

A. Goudeau, F. Dubois, 1984, The Lancet.

Fulminant hepatitis due to reactivation of chronic hepatitis B virus infection after allogeneic bone marrow transplantation

C. Degott, C. Bréchot, J. Bernuau, 1988, Digestive Diseases and Sciences.

IMMUNE RESPONSE IN NEONATES TO HEPATITIS B VACCINE

B. Yvonnet, P. Coursaget, A. Goudeau, 1982, The Lancet.

Cross-sectional and longitudinal epidemiology of hepatitis B in Senegal.

P. Coursaget, A. Goudeau, J. Chiron, 1981, Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progres en virologie medicale.

Fatal outcome after reactivation of inherited chromosomally integrated HHV‐6A (iciHHV‐6A) transmitted through liver transplantation

C. Gaudy-Graffin, A. Goudeau, H. Agut, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Mutations within the Hepatitis C Virus Genotype 1b E2-PePHD Domain Do Not Correlate with Treatment Outcome

A. Moreau, A. Goudeau, F. Lunel, 2005, Journal of Clinical Microbiology.

Hepatitis C in a French population‐based survey, 1994: Seroprevalence, frequency of viremia, genotype distribution, and risk factors

J. Desenclos, N. Mariotte, A. Goudeau, 1997, Hepatology.

Direct appraisal of latex agglutination testing, a convenient alternative to enzyme immunoassay for the detection of rotavirus in childhood gastroenteritis, by comparison of two enzyme immunoassays and two latex tests

A. Goudeau, F. Denis, G. Piñon, 1985, Journal of clinical microbiology.

Hepatitis B, C, D, and E markers in rural equatorial African villages (Gabon).

O. Traoré, P. Roingeard, A. Goudeau, 1995, The American journal of tropical medicine and hygiene.

Hepatitis-B vaccination in the elderly.

N. Gualde, J. Michel, A. Goudeau, 1984, The Journal of infectious diseases.

Genetic diversity of the hepatitis C virus: impact and issues in the antiviral therapy.

C. Gaudy-Graffin, A. Goudeau, S. Vallet, 2007, World journal of gastroenterology.

Hepatitis b virus antigens in human primary hepatocellular carcinoma tissues

P. Coursaget, A. Goudeau, J. Chiron, 1979, International journal of cancer.

Incidence and significance of hepatitis B e antigen and antibody in postnecrotic cirrhosis and primary hepatocellular carcinoma

P. Coursaget, A. Goudeau, J. Drucker, 1978, Journal of clinical microbiology.

Hepatitis B virus DNA in primary hepatocellular carcinoma tissue

P. Coursaget, J. Summers, A. Goudeau, 1978, Journal of medical virology.

IMMUNE RESPONSES TO HEPATITIS B VACCINE

P. Coursaget, A. Goudeau, C. Kattamis, 1981, The Lancet.

Immunogenicity and safety in newborns of a new recombinant hepatitis B vaccine containing the S and pre-S2 antigens.

J Huchet, P. Vermeulen, A. Goudeau, 1991, Vaccine.

Lower serum hepatitis C virus RNA titers in patients with concurrent chronic hepatitis B virus infection.

P. Roingeard, Y. Bacq, A. Goudeau, 1994, The Journal of infectious diseases.

Epidemiology and erdication strategy for hepatitis B in Europe

A. Goudeau, 1990 .

[Perinatal transmission of the hepatitis B virus in Paris region].

A. Goudeau, Y. Brossard, F. Dubois, 1991, Pathologie-biologie.

Frequency of early in utero HIV‐1 infection: a blind DNA polymerase chain reaction study on 100 fetal thymuses

H. Agut, J. Roume, C. Bréchot, 1995, AIDS.

Hepatitis B vaccine: further studies in children with previously acquired hepatitis B surface antigenemia

B. Yvonnet, P. Coursaget, A. Goudeau, 1983, Infection and immunity.

Active immunization against hepatitis B in an area of high endemicity. Part II: Prevention of early infection of the child.

P. Coursaget, A. Goudeau, J. Chiron, 1981, Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progres en virologie medicale.

Non-A, non-B fulminant viral hepatitis in France in returnees from Asia and Africa

J. Bernuau, A. Goudeau, J. Benhamou, 1987, Digestive Diseases and Sciences.

Fulminant viral hepatitis and pregnancy in Algeria and France.

A. Goudeau, C. Gaudebout, J. Benhamou, 1986, Annals of tropical medicine and parasitology.

Immune response to synthetic peptides of hepatitis delta antigen

P. Roingeard, A. Goudeau, F. Dubois, 1993, Journal of clinical microbiology.

Hepatitis delta virus infection in French male HBsAg‐positive homosexuals

P. Roingeard, C. Bréchot, S. Pol, 1989, Hepatology.

Thymic abnormalities in fetuses aborted from human immunodeficiency virus type 1 seropositive women.

C. Griscelli, J. Roume, C. Bréchot, 1992, Pediatrics.

Direct investigation of protein RNA-binding domains using digoxigenin-labelled RNAs and synthetic peptides: application to the hepatitis delta antigen.

P. Roingeard, A. Goudeau, F. Poisson, 1995, Journal of virological methods.

Characterization of RNA-binding domains of hepatitis delta antigen.

P. Roingeard, R. Calogero, A. Goudeau, 1993, The Journal of general virology.

Vaginal self-sampling is a cost-effective way to increase participation in a cervical cancer screening programme: a randomised trial

B. Giraudeau, C. Gaudy-Graffin, A. Goudeau, 2014, British Journal of Cancer.

Accuracy of dry vaginal self-sampling for detecting high-risk human papillomavirus infection in cervical cancer screening: a cross-sectional study.

B. Giraudeau, C. Gaudy-Graffin, A. Goudeau, 2014, Gynecologic oncology.

Interaction between hepatitis delta virus-encoded proteins and hepatitis B virus envelope protein domains.

C. Hourioux, P. Roingeard, C. Sureau, 1998, The Journal of general virology.

Typing of urogenital, maternal, and neonatal isolates of Haemophilus influenzae and Haemophilus parainfluenzae in correlation with clinical source of isolation and evidence for a genital specificity of H. influenzae biotype IV

J. Musser, R. Selander, A. Goudeau, 1989, Journal of clinical microbiology.

Large scale purification of hepatitis B surface antigen (HBsAg).

P. Coursaget, A. Goudeau, F. Barin, 1978, Annals of Microbiology.

Is hepatitis C virus NS3 protease quasispecies heterogeneity predictive of progression from cirrhosis to hepatocellular carcinoma?

H. Hotta, J. Trinchet, M. Beaugrand, 2007, Journal of viral hepatitis.

Genetic heterogeneity of the NS3 protease gene in hepatitis C virus genotype 1 from untreated infected patients

B. Picard, A. Goudeau, J. Nousbaum, 2005, Journal of Medical Virology.

Prevalence and significance of hepatitis C virus (HCV) viremia in HCV antibody-positive subjects from various populations

J. Tichet, Y. Bacq, A. Goudeau, 1993, Journal of clinical microbiology.

Rapid and sustained autologous neutralizing response leading to early spontaneous recovery after HCV infection.

A. Moreau, F. Depaulis, Y. Bacq, 2013, Virology.

Interest of simultaneous Chlamydia trachomatis and Neisseria gonorrhoeae screening at the time of preabortion consultation.

A. Goudeau, P. Lanotte, G. Body, 2012, Contraception.

Antibodies to ATLV/HTLV-1 in Africa

M. Dietrich, A. Fleming, A. Goudeau, 2005, Medical Microbiology and Immunology.

Site-directed serology using synthetic oligopeptides representing the C-terminus of the external glycoproteins of HIV-1, HIV-2, or SIVmac may distinguish subtypes among primate lentiviruses.

R. Mayer, A. Goudeau, M. Essex, 1991, AIDS research and human retroviruses.

Significance of Pretreatment Analysis of Hepatitis C Virus Genotype 1b Hypervariable Region 1 Sequences To Predict Antiviral Outcome

A. Moreau, A. Goudeau, F. Lunel, 2003, Journal of Clinical Microbiology.

Comparison of DNA Enzyme Immunoassay and Line Probe Assays (Inno-LiPA HCV I and II) for Hepatitis C Virus Genotyping

R. Christen, A. Goudeau, S. Le Pogam, 1998, Journal of Clinical Microbiology.

Sequence and Functional Analysis of the Envelope Glycoproteins of Hepatitis C Virus Variants Selectively Transmitted to a New Host

B. Giraudeau, E. Blanchard, A. Moreau, 2013, Journal of Virology.

New Host Virus Variants Selectively Transmitted to a Envelope Glycoproteins of Hepatitis C Sequence and Functional Analysis of the

E. Blanchard, A. Moreau, P. Roingeard, 2013 .

Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines.

M. Levine, C. Tacket, J. Robbins, 1986, The Journal of infectious diseases.

Competitive enzyme-immunoassays using native viral antigens to discriminate between HIV-1 and HIV-2 infections.

A. Goudeau, F. Barin, S. M'boup, 1990, Journal of virological methods.

Genetic features of Pseudomonas aeruginosa isolates from cystic fibrosis patients compared with those of isolates from other origins.

A. Goudeau, P. Lanotte, R. Quentin, 2004, Journal of medical microbiology.

COMBINED PAEDIATRIC VACCINES: GOOD RESULT FROM CLINICAL TRIALS IN ITALY AND GREECE

J. D. L. Torre, C. Roure, A. Meheus, 1997 .

Enhanced production of hepatitis B surface antigen by PLC/PRF/5 hepatoma cell line using sodium butyrate and dexamethasone treatments

C. Sureau, A. Goudeau, F. Barin, 1984 .

Infection due to hepatitis delta virus in Africa: report from Senegal and review.

P. Roingeard, S. Mboup, J. Sankalé, 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[Prevention of perinatal hepatitis B virus transmission. Epidemiology and cost/efficacy ratio in the Paris region].

A. Goudeau, Y. Brossard, F. Dubois, 1991, Presse medicale.

Hepatitis C Virus-Like Particle Morphogenesis

E. Blanchard, S. Trassard, P. Roingeard, 2002, Journal of Virology.

Immunologic and virologic status of multitransfused patients: role of type and origin of blood products. By the AIDS-Hemophilia French Study Group.

A. Goudeau, C. Guérois, Y. Laurian, 1985, Blood.

[Seroepidemiology of hepatitis A in six departments in West-Central France in 1991].

J. Tichet, A. Goudeau, S. Vol, 1992, Gastroenterologie clinique et biologique.

CMV Infection in the Donor and Increased Kidney Graft Loss: Impact of Full HLA‐I Mismatch and Posttransplantation CD8+ Cell Reduction

F. Bruyère, C. Forconi, P. Gatault, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Case report: Benefits of quantitative polymerase chain reaction in the clinical management of herpes simplex virus 1 infection with prominent hepatitis and unusual secondary progression

C. Hommet, K. Mondon, J. Cottier, 2012, Journal of medical virology.

VIRUS CARRIAGE IN SYMPTOM-FREE BLOOD DONOR POSITIVE FOR HTLV-III ANTIBODY

A. Goudeau, F. Barin, P. Choutet, 1985, The Lancet.

Immune response to a major epitope of p24 during infection with human immunodeficiency virus type 1 and implications for diagnosis and prognosis

A. Goudeau, B. Mandrand, F. Barin, 1991 .

Vaccine against hepatitis B — 18 months prevention in a high risk setting

P. Coursaget, P. Bagros, A. Goudeau, 1978, Medical Microbiology and Immunology.

Evaluation of a rapid latex test for direct detection ofStreptococcus agalactiae in various obstetrical and gynaecological disorders

A. Goudeau, R. Quentin, F. Pierre, 2005, European Journal of Clinical Microbiology and Infectious Diseases.

Immune response to hepatitis B vaccination at birth

B. Yvonnet, P. Coursaget, A. Goudeau, 1985 .

Enigmatic occurrence of NDM-7 enzyme in the community.

P. François, S. Diene, F. Chopin, 2016, International journal of antimicrobial agents.

A simple procedure to generate chimeric Pr55gag virus-like particles expressing the principal neutralization domain of human immunodeficiency virus type 1.

P. Roingeard, F. Mallet, A. Goudeau, 1995, Journal of Virological Methods.

High antigenic cross-reactivity of the V3 consensus sequences of HIV-1 gp120.

A. Goudeau, F. Barin, D. Brand, 1993, AIDS research and human retroviruses.

Localized scleroderma is not a Borrelia burgdorferi infection in France.

L. Vaillant, A. Goudeau, 1992, Dermatology.

Could serum HBV DNA level in the early phase of acute hepatitis B predict evolution to chronic HBV carriage?

P. Roingeard, Y. Bacq, A. Goudeau, 1997, Journal of hepatology.

[Etiological diagnosis of viral hepatitis in 1987].

A. Goudeau, F. Dubois, 1987, Gastroenterologie clinique et biologique.

Temporal development and prognostic value of antibody response to the major neutralizing epitopes of gp120 during HIV‐1 infection

A. Goudeau, F. Barin, F. Simon, 1997, Journal of medical virology.

Vaccine against hepatitis B in children: prevention of hepatitis in a pediatric hemodialysis unit.

P. Coursaget, H. Nivet, A. Goudeau, 1982, The International journal of pediatric nephrology.

Hepatitis B vaccine: immunization of children and newborns in an endemic area (Senegal).

B. Yvonnet, P. Coursaget, A. Goudeau, 1983, Developments in biological standardization.

Two Successive Hepatitis C Virus Infections in an Intravenous Drug User

Y. Bacq, A. Goudeau, S. Le Pogam, 2000, Journal of Clinical Microbiology.

Impact on the medical decision-making process of multiplex PCR assay for respiratory pathogens

P. Diot, C. Gaudy-Graffin, A. Goudeau, 2017, Epidemiology and Infection.

[Study of hospitalizations for pneumococcal pneumoniae in Centre region, 2004-2008].

A. Goudeau, E. Rusch, L. Bernard, 2012, Revue d'epidemiologie et de sante publique.

[Mutation analysis of ISDR and V3 domains of hepatitis C virus NS5A region before interferon therapy with or without ribavirin].

A. Goudeau, F. Lunel, C. Payan, 2003, Pathologie-biologie.

[Autochthonous hepatitis E in France and consumption of raw pig meat].

Y. Bacq, C. Gaudy-Graffin, A. Goudeau, 2007, Gastroenterologie clinique et biologique.

The kinetics of antibodies against hepatitis C virus may predict viral clearance in exposed hemophiliacs.

Y. Gruel, Y. Bacq, A. Goudeau, 1998, The Journal of infectious diseases.

Antibody to hepatitis B core antigen in chronic active hepatitis.

P. Coursaget, C. Degott, P. Bories, 1978, British medical journal.

[Pediatric osteoarticular infections caused by Kingella kingae from 1995 to 2006 at CHRU de Tours].

A. Goudeau, P. Lanotte, L. Mereghetti, 2008, Annales de biologie clinique.

[Thyroid function and autoimmunity in 215 patients seropositive for the hepatitis C virus].

Y. Bacq, A. Goudeau, A Goudeau, 1998, Annales d'endocrinologie.

Acute measles encephalitis of the delayed type: neuroradiological and immunological findings.

A. Goudeau, C. Billard, D. Degenne, 1992, European neurology.

[Prevalence of extended-spectrum beta-lactamases of the CTX-M type producing Escherichia coli and Klebsiella pneumoniae in Bretonneau hospitals (CHRU Tours)].

A. Goudeau, A. Grillon, P. Lanotte, 2010, Pathologie et biologie.

Analysis of the antibody response in humans with a new inactivated hepatitis A vaccine.

A. Goudeau, C. Xueref, P. Brasseur, 1996, Biologicals (Print).

Hepatitis B vaccine: clinical trials in high-risk settings in France. (September 1975-September 1982).

P. Coursaget, A. Goudeau, F. Barin, 1983, Developments in biological standardization.

[1997-2007, 10 years of monitoring the evolution of resistance of Streptococcus pneumoniae to antibiotics in the region Centre; review of the Pneumococcus network].

D. Poisson, P. Amirault, A. Goudeau, 2010, Pathologie-biologie.

SAFETY OF HEPATITIS-B VACCINES: NO EVIDENCE OF AUTOIMMUNITY

P. Coursaget, D. Doniach, A. Goudeau, 1979, The Lancet.

Hepatitis B vaccine: efficacy in high-risk settings, a two-year study.

P. Coursaget, P. Bagros, A. Goudeau, 1978, Intervirology.

Efficacy of vaccine against hepatitis B; epidemiological data.

P. Coursaget, P. Bagros, A. Goudeau, 1977, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.

Prevalence, risk factors, and impact of isolated antibody to hepatitis B core antigen and occult hepatitis B virus infection in HIV-1-infected pregnant women.

S. Nanta, C. Gaudy-Graffin, A. Goudeau, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

UNCORRECTED PROOF 1 Accuracy of dry vaginal self-sampling for detecting high-risk human 2 papillomavirus infection in cervical cancer screening:

C. Gaudy-Graffin, A. Goudeau, J. Viguier, 2014 .

Diagnostic performance of multiplex PCR on pulmonary samples versus nasopharyngeal aspirates in community-acquired severe lower respiratory tract infections

A. Goudeau, C. Le Brun, D. Garot, 2018, Journal of Clinical Virology.

Congenital Trypanosomiasis in Child Born in France to African Mother

A. Goudeau, P. Lanotte, B. de Toffol, 2016, Emerging infectious diseases.

Air Contamination around Patients Colonized with Multidrug-Resistant Organisms

A. Goudeau, P. Lanotte, L. Bernard, 2012, Infection Control & Hospital Epidemiology.

Etiology and clinical pattern of fulminant hepatitis in Iraq.

A. Goudeau, F. Dubois, S. Rassam, 1991, Annals of Saudi medicine.

A. Goudeau, F. Denis, G. Piñon, 1985, Journal of clinical microbiology.

Long-Term Hepatitis B Virus (HBV) Response to Lamivudine-Containing Highly Active Antiretroviral Therapy in HIV-HBV Co-Infected Patients in Thailand

A. Moreau, C. Gaudy-Graffin, A. Goudeau, 2012, PloS one.

Detection and typing of human papillomaviruses by in situ hybridization with biotinylated oligonucleotide mixtures

A. Goudeau, M. Joannes, M. Jourdan, 1995, Journal of medical virology.

Acute viral hepatitis: An aetiological study of 253 patients

A. Goudeau, F. Dubois, S. Rassam, 1989, Journal of gastroenterology and hepatology.

A particular hepatitis C virus protease NS3 gene pattern in a patient not responding to interferon-ribavirin therapy

B. Picard, A. Goudeau, J. Nousbaum, 2004, European Journal of Clinical Microbiology and Infectious Diseases.